Aly M. Abdelrahman
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes 5
- Acute Kidney Injury Research 5
- Behavioral Neuroscience top 10%
-
- Chemotherapy-induced organ toxicity mitigation 12
-
- Receptor Mechanisms and Signaling 13
-
- Neuropeptides and Animal Physiology 9
-
- Nitric Oxide and Endothelin Effects 6
-
- Acute Lymphoblastic Leukemia research 6
-
- Liver Disease and Transplantation 5
Aly M. Abdelrahman
63 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 101
- Nephrology 118
- Behavioral Neuroscience 59
- Pathology and Forensic Medicine 291
- Endocrinology, Diabetes and Metabolism 219
- Cardiology and Cardiovascular Medicine 289
Countries citing papers authored by Aly M. Abdelrahman
This map shows the geographic impact of Aly M. Abdelrahman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aly M. Abdelrahman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aly M. Abdelrahman more than expected).
Fields of papers citing papers by Aly M. Abdelrahman
This network shows the impact of papers produced by Aly M. Abdelrahman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aly M. Abdelrahman. The network helps show where Aly M. Abdelrahman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aly M. Abdelrahman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 5 | |
| 8 | 2017 | 4 | |
| 9 | 2016 | 35 | |
| 10 | 2015 | 27 | |
| 11 | 2009 | 44 | |
| 12 | 2008 | 12 | |
| 13 | 2006 | 9 | |
| 14 | 2005 | 3 | |
| 15 | 2002 | 2 | |
| 16 | 2002 | 25 | |
| 17 | 1995 | 10 | |
| 18 | 1994 | 75 | |
| 19 | Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone. | 1993 | 17 |
| 20 | 1992 | 12 |
About Aly M. Abdelrahman
Aly M. Abdelrahman is a scholar working on Nephrology, Applied Microbiology and Biotechnology and Behavioral Neuroscience, having authored 69 papers that have together received 1.2k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (13 papers), Chemotherapy-induced organ toxicity mitigation (12 papers), Neuropeptides and Animal Physiology (9 papers), Nitric Oxide and Endothelin Effects (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Chronic Kidney Disease and Diabetes (5 papers), Liver Disease and Transplantation (5 papers) and Acute Kidney Injury Research (5 papers). The work is most often cited by research in Nephrology (118 citations), Behavioral Neuroscience (59 citations) and Pathology and Forensic Medicine (291 citations). Aly M. Abdelrahman has collaborated with scholars based in Oman, Canada and Egypt. Frequent co-authors include Catherine C.Y. Pang, Entesar F. Amin, Badreldin H. Ali, Mohamed Ibrahim, Salwa A. Ibrahim, Priyadarsini Manoj, Mina Kelleni, Mohammed Ashique, Azza A. K. El‐Sheikh and Yousuf Al Suleimani. Their work appears in journals such as British Journal of Pharmacology, Clinical Chemistry and Journal of Materials Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.